Price
No data yet.
Social Signal Score
Analyst Ratings
4 analystsRevenue
$347.0K-77.41%Analyst Estimates
Consensus estimates, not results. Via Financial Modeling Prep.
Company Profile
- CEO
- Ofer Haviv
- Sector
- Healthcare
- Industry
- Biotechnology
- Employees
- 52
- Beta
- 0.78
- Country
- IL
- Piotroski score
- 1 / 9 (Weak)
- Altman Z-score
- -32.45
Financials
Revenue
$347.0K-77.4%Net Income
$-1.77MEBITDA
$-2.29MFree Cash Flow
$-2.11MEPS (diluted)
$-0.14Shares Outstanding (diluted)
12.20M-52.3%Operating Expenses
$2.43MCash & Debt
$9.35MReturn of Capital
$2.55MQuote
Valuation & Ratios
Returns & Efficiency
Revenue & Net Income (Annual)
| Fiscal Year | Revenue | Net Income | EPS |
|---|---|---|---|
| 2025 | $3.85M | $-8.48M | $-1.08 |
| 2024 | $5.58M | $-16.48M | $-2.89 |
| 2023 | $2.98M | $-23.88M | $-5.23 |
| 2022 | $1.68M | $-26.64M | $-6.46 |
| 2021 | $930.0K | $-27.79M | $-0.68 |
| 2020 | $1.04M | $-23.37M | $-0.64 |
| 2019 | $753.0K | $-18.11M | $-0.70 |
| 2018 | $1.75M | $-20.76M | $-0.81 |
| 2017 | $3.38M | $-20.84M | $-0.81 |
| 2016 | $6.54M | $-19.59M | $-0.77 |
| 2015 | $11.13M | $-17.21M | $-0.68 |
| 2014 | $14.51M | $-14.53M | $-0.58 |
| 2013 | $17.58M | $-8.88M | $-0.45 |
| 2012 | $17.07M | $-2.52M | $-0.14 |
Valuation
EVGNhas no positive reported earnings per share, so an earnings-multiple projection can't be built for it. Companies are valued on other measures at this stage — revenue growth, cash burn, or book value — none of which this calculator models.
Signal Score (90d)
50+0.00%Social Signal Score
Mentions (8)
- Newsprnewswire.com·6d ago·Neutral
Evogene Reports Nasdaq Grants Additional 180-Day Period to Regain Minimum Bid Price Compliance REHOVOT, Israel, Sept. 30, 2026 /PRNewswire/ -- Evogene Ltd.
View source ↗ - Newsnewsfilecorp.com·22d ago·Negative
… Attend the ArcStone-Kingswood Growth Summit 2026 in Toronto Vancouver, British Columbia--(Newsfile Corp. - September 14, 2026) - EverGen Infrastructure Corp. (TSXV: EVGN) (OTCQB: EVGIF) is pleased to announce its participation in the upcoming 3 rd Annual ArcStone-Kingswood Growth Summit in Toronto, taking place on September 16, 2026, at the Sheraton Center Toronto Hotel. Chase Edgelow, Co-founder & Chief Executive Office of EverGen, will participate as a Featured Company and will hold one-on-on…
View source ↗ - Newsprnewswire.com·36d ago·Positive
…ready implemented and vote FOR all Evogene nominees on September 4, 2026, Annual General Meeting REHOVOT, Israel, Aug. 31, 2026 /PRNewswire/ -- Evogene Ltd. (NASDAQ: EVGN) (TASE: EVGN), a pioneer in computational chemistry specializing in the generative design of small molecules for the pharmaceutical and agricultural industries, today responded to the latest communication from dissident shareholders L.I.A.
View source ↗ - Newsbusinesswire.com·40d ago·Negative
EverGen Infrastructure Reports Q2 2026 Results VANCOUVER, British Columbia--(BUSINESS WIRE)--EverGen Infrastructure Corp. (“EverGen” or the “Company”) (TSXV: EVGN) (OTCQB: EVGIF), today reported financial results as at and for Q2 2026. All amounts are in Canadian dollars and are presented in thousands of dollars unless otherwise stated and have been prepared in accordance with IFRS. Financial Highlights The following table presents EverGen's Consolidated Financial and Operating Summary: Three …
View source ↗ - Newsprnewswire.com·42d ago·Positive
…es, and to disregard the Pure Capital Nominees, at the September 4, 2026, Annual General Meeting REHOVOT, Israel, Aug. 25, 2026 /PRNewswire/ -- Evogene Ltd. (NASDAQ: EVGN) (TASE: EVGN), a pioneering company in computational chemistry, specializing in the generative design of small molecules for the pharmaceutical and agricultural industries, today announced that leading independent proxy advisory firms Institutional Shareholder Services ("ISS") and Glass Lewis have recommended that Evogene share…
View source ↗ - Newsseekingalpha.com·48d ago·Positive
Evogene Ltd. (EVGN) Q2 2026 Earnings Call Transcript Evogene Ltd. (EVGN) Q2 2026 Earnings Call Transcript
View source ↗ - Newsprnewswire.com·49d ago·Negative
…to approximately 110 billion molecules, supported by advanced AI models and autonomous AI Agents REHOVOT, Israel, Aug. 18, 2026 /PRNewswire/ -- Evogene Ltd. (NASDAQ: EVGN) (TASE: EVGN), a pioneering company in computational chemistry, specializing in the generative design of small molecules for the pharmaceutical and agricultural industries, today announced its financial results for the first half of 2026 and second quarter ended June 30, 2026, and provided an update on its strategic and operati…
View source ↗ - Newsprnewswire.com·53d ago·Neutral
…ssident Shareholders Situation Zoom conference call scheduled for August 18, 2026, at 9:00 AM ET REHOVOT, Israel, Aug. 14, 2026 /PRNewswire/ -- Evogene Ltd. (Nasdaq: EVGN) (TASE: EVGN), a pioneering company in computational chemistry, specializing in the generative design of small molecules for the pharmaceutical and agricultural industries, announced today that its Chairman, Nir Nimrodi, will join the Company's upcoming quarterly results conference call on August 18, 2026.
View source ↗
Earnings
Thu, Nov 19(in 6 weeks)
Consensus estimate $-0.19 per share
Typical surprise +1.6% (median, so one quarter with a near-zero estimate can't distort it)
- Tue, Aug 18$-0.13 vs $-0.27beat
- Wed, May 20$-0.60 vs $-0.27miss
- Thu, Mar 5$-0.61 vs $-0.26miss
- Thu, Nov 20$-0.31 vs $-0.26miss
- Tue, Aug 19$-0.62 vs $-0.63beat
- Wed, May 21$-0.38 vs $-0.63beat
Estimates and results for EVGN via Financial Modeling Prep. Beating consensus says the company cleared the bar analysts set, not that the business grew.
Insider trading
Open-market buys and sells by EVGN officers and directors.
- Bought
- $693k
- Sold
- —
3 trades
0 trades
- Recanati Leonbought
- Recanati Leonbought
- Tarcic Gabibought
56 further Form 4 entries are share awards, option exercises or shares withheld for tax. Those are compensation, not trades, so they are excluded above. Buying is the stronger signal: an insider spends their own money for one reason. Selling has many innocent explanations — tax, diversifying, a house — so it says far less than it appears to. Via SEC filings.
Congress trades
No disclosed congressional trades in EVGN.
Self-reported filings, amounts as brackets. Via Senate/House disclosures.